Rayyan vs RevMan
Rayyan
rayyan.aiRevMan
cochrane.orgSide by side
| Figure | Rayyan | RevMan |
|---|---|---|
| Price from | $4.99/mo | £6.67/mo |
| Free plan | Yes | Yes |
| Free trial | — | Yes |
| Open source | — | — |
| Web | Yes | Yes |
| Windows | — | Yes |
| macOS | — | Yes |
| Linux | — | Yes |
| iOS | Yes | — |
| Android | Yes | — |
| API | Yes | — |
| Plans published | 5 | 11 |
| Spec score · Systematic Review Software | 8.1 (#8) | 8.7 (#3) |
| Spec score · Literature Review Software | 8.0 (#9) | 8.7 (#3) |
| API | API access includes programmatic access to reviews, references, decisions, and metadata, an official Python SDK, workflow automation, and external system integrations. | Cochrane documents Review Document, ReviewDB and Group APIs, including a REST ReviewDB endpoint at api.cochrane.org. |
| Headquarters | Cambridge, Massachusetts, USA | London, United Kingdom |
| Integrations | Rayyan accepts exported reference files from external databases and reference managers; it says there is no direct database connection. | RevMan can import study data and references from Covidence, and RIS reference imports can use data from Crossref, PubMed, or CRS. |
| Purpose | Rayyan is a systematic review platform for teams conducting transparent, auditable, and reproducible evidence reviews. | RevMan is Cochrane’s software for producing transparent systematic reviews, guiding authors from structured data entry and analysis through result visualization. |
| Security | Rayyan's enterprise page states HIPAA and GDPR compliance, SOC 2 controls, encryption in transit and at rest, and support for SAML 2.0, OAuth, and MFA. | Cochrane states that RevMan Web is GDPR compliant, hosted on AWS with SOC 2 Type 2 controls, uses 256-bit SSL, encryption at rest, OIDC single sign-on, permission separation, monitoring and daily backups. |
| Support | The pricing page lists Standard support for Free and Essential, priority support for Advanced and Business / Academic, and dedicated support for Enterprise. | Cochrane directs users to its Support Team and provides how-to articles, screencasts and release notes. |
Plans
Rayyan
- FreeFree
- Essential$4.99 a month
- Advanced$8.33 a month
- Business / Academic$41.67 a month
- EnterprisePriced on request
RevMan
- Cochrane author accessFree
- Cochrane author accessFree
- Practice reviewFree
- Individual student annual subscription£80 a year
- Student£80 a year
- Academic£100 a year
- Individual academic annual subscription£100 a year
- Individual standard annual subscription£130 a year
- Standard rate£130 a year
- OrganizationPriced on request
In their own words
Rayyan
Rayyan is a platform for teams carrying out systematic evidence reviews, with workflows intended to be transparent, auditable, and reproducible. Its process spans reference import, collaboration, deduplication, title and abstract screening, full-text screening, data extraction, risk-of-bias assessment, and reporting. ResearchPilot AI Reviewer screens articles against criteria set by the user and gives decisions with reasoning notes. The Analyzer suggests inclusion or exclusion with justification, while the researcher retains final decision-making. ResearchPilot can also extract answers to custom questions from PDFs and metadata, highlight relevant passages, and let users inspect the answers. References are imported from exported files rather than a direct database connection. The API offers programmatic access to reviews, references, decisions, and metadata, plus workflow automation and external integrations. Rayyan is available on Android, iOS, web, and through an API. The Free plan allows three active reviews and two free reviewers; paid options start at $8.33 a month per seat, billed annually. Free mobile access is limited; Essential and higher provide unlimited mobile access.
RevMan
RevMan is Cochrane’s software for building systematic reviews, from structured data entry and analysis to presenting results. It supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. Authors can edit separate parts of a review at the same time and see who else is working on it. Analysis options include pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel, and inverse-variance models. Built-in outputs include forest, SROC, and funnel plots, risk-of-bias assessments, and PRISMA flow diagrams. Authors can work from ready-made or custom templates and structured headings with Cochrane methodological guidance. RevMan imports study data and references from Covidence, and RIS reference imports can draw on Crossref, PubMed, or CRS. A free practice review is deleted after 30 days and permits one person, with no data export. Free access is also available to authors working on Cochrane Reviews. Individual annual plans are £80 a year for eligible students, £100 a year for eligible academics, and £130 a year for standard subscriptions; VAT applies in the EU and UK.